News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,441 Results
Type
Article (2087)
Company Profile (22)
Press Release (68332)
Section
Business (31519)
Career Advice (50)
Deals (5106)
Drug Delivery (3)
Drug Development (8249)
Employer Resources (16)
FDA (1251)
Job Trends (1790)
News (44047)
Policy (2372)
Tag
Academia (133)
Academic (1)
Accelerated approval (1)
Allergies (12)
Alliances (2521)
ALS (5)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (26)
Approvals (1335)
Artificial intelligence (29)
Autoimmune disease (6)
Bankruptcy (19)
Best Places to Work (1670)
Biosimilars (9)
Biotechnology (17)
Bladder cancer (29)
Brain cancer (5)
Breast cancer (101)
Cancer (591)
Cardiovascular disease (45)
Career advice (44)
CAR-T (10)
CDC (2)
Cell therapy (40)
Cervical cancer (6)
Clinical research (7761)
Collaboration (76)
Compensation (64)
COVID-19 (151)
CRISPR (5)
C-suite (21)
Cystic fibrosis (15)
Data (887)
Depression (7)
Diabetes (43)
Diagnostics (669)
Digital health (5)
Diversity, equity & inclusion (4)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (9)
Earnings (29157)
Employer branding (2)
Employer resources (13)
Events (7280)
Executive appointments (29)
FDA (1757)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (7)
Funding (76)
Gene editing (12)
Generative AI (3)
Gene therapy (54)
GLP-1 (107)
Government (283)
Guidances (261)
Healthcare (2182)
HIV (7)
Huntington's disease (1)
IgA nephropathy (10)
Immunology and inflammation (23)
Immuno-oncology (3)
Indications (11)
Infectious disease (172)
Inflammatory bowel disease (21)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (15)
Interviews (7)
IPO (3927)
IRA (1)
Job creations (208)
Job search strategy (43)
Kidney cancer (5)
Labor market (9)
Layoffs (31)
Legal (452)
Liver cancer (13)
Lung cancer (90)
Lymphoma (64)
Machine learning (2)
Management (3)
Manufacturing (37)
MASH (27)
Medical device (1621)
Medtech (1628)
Mergers & acquisitions (1279)
Metabolic disorders (138)
Multiple sclerosis (25)
NASH (2)
Neurodegenerative disease (16)
Neuropsychiatric disorders (9)
Neuroscience (228)
NextGen: Class of 2025 (550)
Non-profit (283)
Now hiring (1)
Obesity (54)
Opinion (11)
Ovarian cancer (13)
Pain (9)
Pancreatic cancer (23)
Parkinson's disease (20)
Partnered (5)
Patents (30)
Patient recruitment (25)
Peanut (6)
People (2139)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase I (1854)
Phase II (3085)
Phase III (3308)
Pipeline (1374)
Policy (9)
Postmarket research (341)
Preclinical (590)
Press Release (1)
Prostate cancer (25)
Radiopharmaceuticals (21)
Rare diseases (71)
Real estate (293)
Recruiting (7)
Regulatory (1985)
Reports (12)
Research institute (157)
Resumes & cover letters (5)
Rett syndrome (2)
RNA editing (2)
RSV (10)
Schizophrenia (16)
Series A (13)
Series B (10)
Service/supplier (1)
Sickle cell disease (12)
Special edition (3)
Spinal muscular atrophy (6)
Startups (147)
Stomach cancer (5)
Supply chain (3)
Tariffs (4)
The Weekly (3)
Vaccines (94)
Venture capital (3)
Weight loss (36)
Women's health (6)
Date
Last 7 days (6)
Last 30 days (194)
Last 365 days (4409)
2025 (4409)
2024 (5259)
2023 (5834)
2022 (6767)
2021 (7020)
2020 (6180)
2019 (4567)
2018 (3450)
2017 (3268)
2016 (2335)
2015 (3064)
2014 (2028)
2013 (1320)
2012 (1753)
2011 (2002)
2010 (1880)
Location
Africa (60)
Alabama (7)
Arizona (17)
Arkansas (2)
Asia (3619)
Australia (604)
California (1501)
Canada (407)
China (101)
Colorado (72)
Connecticut (86)
Delaware (56)
Europe (10279)
Florida (184)
Georgia (63)
Idaho (3)
Illinois (84)
India (4)
Indiana (110)
Iowa (1)
Japan (44)
Kansas (10)
Kentucky (6)
Louisiana (7)
Maine (15)
Maryland (164)
Massachusetts (953)
Michigan (37)
Minnesota (77)
Missouri (12)
Montana (3)
Nebraska (3)
Nevada (9)
New Hampshire (9)
New Jersey (494)
New Mexico (1)
New York (430)
North Carolina (181)
Northern California (796)
Ohio (28)
Oregon (2)
Pennsylvania (284)
South America (89)
South Carolina (1)
Southern California (554)
Tennessee (30)
Texas (207)
United States (5204)
Utah (42)
Vermont (1)
Virginia (14)
Washington D.C. (5)
Washington State (147)
Wisconsin (10)
70,441 Results for "47".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
December 17, 2025
·
4 min read
Press Releases
PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets
December 10, 2025
·
5 min read
Press Releases
Cell And Gene Therapy Clinical Trials Market Accelerates from USD 12.47 Billion in 2025 to USD 45.31 Billion by 2034
December 3, 2025
·
1 min read
Press Releases
Alkeus Pharmaceuticals Announces Gildeuretinol Data Will Be Presented During the 13th International FLORetina ICOOR Congress December 4–7 in Florence, Italy
December 4, 2025
·
3 min read
Press Releases
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101
October 21, 2025
·
4 min read
Press Releases
Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025
November 3, 2025
·
1 min read
Press Releases
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
December 17, 2025
·
10 min read
Press Releases
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
December 3, 2025
·
7 min read
Press Releases
Pinetree Therapeutics Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology
October 28, 2025
·
4 min read
Press Releases
HanchorBio’s Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology
October 23, 2025
·
5 min read
1 of 7,045
Next
